Browsing Tag

Partnering

580 posts

Novartis in $1.1-Billion mAb Mfg Pact with MorphoSys, Galapagos
By

By
Novartis has formed a deal with MorphoSys AG, a Planegg, Germany-based developer of antibodies, and Galapagos NV, a Mechelen, Belgium-based clinical-stage pharmaceutical company, to develop and commercialize their joint investigational,…

AbbVie To Grant Mylan License to Launch Humira Biosimilar
By

By
AbbVie has signed patent license agreements with Mylan over Mylan’s proposed biosimilar to AbbVie’s Humira (adalimumab). Humira is AbbVie’s top-selling drug with 2017 sales of $18.43 billion. Under the agreements,…

AstraZeneca in Gene-Therapy Pact
By

By
MedImmune, AstraZeneca’s global biologics research and development arm, has partnered with 4D Molecular Therapeutics (4DMT), a company specializing in gene-therapy vector discovery and product development, to develop and commercialize a…

Novartis Partners with French CDMO for CAR-T-Cell Therapy Mfg
By

By
Novartis has signed an agreement with CELLforCURE, a contract development and manufacturing organization and part of the biopharmaceutical company, LFB, to produce chimeric antigen receptor T-cell (CAR-T) therapies at CELLforCURE’s…

Genmab, Immatics in $2.8-Billion Deal for Immunotherapies
By

By
Genmab A/S, a Copenhagen, Denmark-based biopharmaceutical company developing therapeutic anti-cancer antibodies, has formed a license pact with Immatics Biotechnologies GmbH, a Tuebingen, Germany-based clinical-stage biopharmaceutical company, to discover and develop…

Sanofi, Evotec Close Deal for Infectious Disease R&D
By

By
Sanofi and Evotec, a Hamburg, Germany-based drug-discovery and development company, have closed their deal to integrate Sanofi’s infectious disease unit into Evotec’s global drug discovery and development operations. In March…

AbbVie, Google-Funded Calico Invest Additional $1 Billion in Age-Related R&D Pact
By

By
AbbVie and Calico, a research and development (R&D) company focused on aging research and therapeutics, and funded by Alphabet, the parent company of Google, have invested an additional $1 billion…

Oncobiologics Launches CDMO Biz; Forms First Contract
By

By
Oncobiologics, a Cranbury, New Jersey-based biopharmaceutical company developing monoclonal antibody (mAb) biosimilars, has launched a contract development and manufacturing (CDMO) business. It further formed a master services agreement (MSA) with…

Pacira, Nuance Biotech in License Pact in China
By

By
Pacira Pharmaceuticals, a Parsippany, New Jersey-based specialty pharmaceutical company, and Nuance Biotech, a Shanghai, China-based specialty pharmaceutical company, have formed an agreement to develop and commercialize Exparel (bupivacaine liposome injectable…

Alexion, Complement Pharma Partner
By

By
Alexion Pharmaceuticals, a New Haven, Connecticut-based pharmaceutical company, and Complement Pharma, a pharmaceutical company headquartered in Amsterdam, the Netherlands, have partnered to co-develop Complement Pharma’s preclinical C6 complement inhibitor for…